Man in serious condition in ICU after developing blood clots ‘linked to AstraZeneca vaccine’ | 7NEWS

7NEWS Australia published this video item, entitled “Man in serious condition in ICU after developing blood clots ‘linked to AstraZeneca vaccine’ | 7NEWS” – below is their description.

A 53-year-old South Australian man is gravely ill in intensive care after suffering a blood clot linked to the AstraZeneca vaccine.

It is our state’s first confirmed case, but authorities believe an elderly woman has fallen victim too.

7NEWS Adelaide at 11.30am, 4pm and 6pm | https://7news.link/3v5HOZh

7NEWS Australia YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


About This Source - 7NEWS Australia

Seven News is the television news service of the Seven Network and, as of 2016, the highest-rating in Australia. The news service draws upon overseas channels for select international coverage. The network’s Director of News and Current Affairs is Craig McPherson.

Recent from 7NEWS Australia:

Cctv captures postie’s delivery fail 1

CCTV captures postie’s delivery fail

Hot air balloon makes emergency landing in Melbourne park

Princess Mary makes first appearance after shock abdication

In This Story: Adelaide

Adelaide is South Australia’s cosmopolitan coastal capital. Its ring of parkland on the River Torrens is home to renowned museums such as the Art Gallery of South Australia, displaying expansive collections including noted Indigenous art, and the South Australian Museum, devoted to natural history. The city’s Adelaide Festival is an annual international arts gathering with spin-offs including fringe and film events.

4 Recent Items: Adelaide

Perth Scorchers v Adelaide Strikers | BBL|13

Australia v West Indies 2023-24 | First Test | Day 3

King Charles and Princess Kate in hospital: ‘No minor matter’ says Royal expert

Head delighted at making Adelaide Oval honour board again | Australia v West Indies 2023-24

In This Story: AstraZeneca

AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.

3 Recent Items: AstraZeneca

Disease X: The next possible global health threat?

CHAOS In Ecuador As Armed Gangsters STORM TV Station! State Of Emergency! – Stay Free #281 PREVIEW

GSK, Amneal, Kaléo delist patents from FDA’s orange book

In This Story: Vaccine

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.

9 Recent Items: Vaccine

‘National incident’ declared over measles outbreak

Southern Africa cholera outbreak: Zambia and Zimbabwe lead vaccine drives

People born 1998-2004 ‘should get measles vaccine’ #measles #vaccine

N.Y. midwife falsified thousands of vaccine records

Vaccines: There’s ‘so much noise’ around facts: Moderna CEO

Vaccine for RSV approved in Australia | 9 News Australia

IT’S OVER! This Fauci SCANDAL Is Just The Tip Of The Iceberg

‘Lunatics have taken over!’ | Neil Oliver on air strikes in Yemen, Britain’s borders and more

They KNEW This Vaccine Data Was TRUE But CENSORED It Anyway!!

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.